| Asthma |
1.75 |
2.90e-1 |
25/31 (80.65%) |
PRG2;HLA-DPA1;EPX;...
|
| Arachidonic acid metabolism |
1.55 |
7.99e-1 |
48/61 (78.69%) |
ALOX5;GPX3;GPX1;...
|
| Thyroid hormone synthesis |
1.50 |
8.20e-1 |
66/75 (88%) |
GPX3;TG;GPX1;...
|
| Glutathione metabolism |
1.47 |
7.30e-1 |
43/57 (75.44%) |
GPX3;GPX1;GGT1;...
|
| Base excision repair |
1.44 |
7.36e-1 |
29/33 (87.88%) |
POLE3;HMGB1;NEIL3;...
|
| Fc epsilon RI signaling pathway |
1.43 |
6.62e-1 |
57/68 (83.82%) |
ALOX5;ALOX5AP;MAPK13;...
|
| Mannose type O-glycan biosynthesis |
1.38 |
8.64e-1 |
14/23 (60.87%) |
RXYLT1;CHST10;POMT1;...
|
| Histidine metabolism |
1.37 |
8.22e-1 |
16/22 (72.73%) |
MAOA;AOC1;ALDH1B1;...
|
| Oxytocin signaling pathway |
1.26 |
8.88e-1 |
128/154 (83.12%) |
GNAI1;CAMK1;ADCY9;...
|
| Renin secretion |
1.22 |
8.82e-1 |
61/69 (88.41%) |
AGT;GNAI1;GNAQ;...
|
| Aminoacyl-tRNA biosynthesis |
1.19 |
8.83e-1 |
15/66 (22.73%) |
NARS2;GATB;LARS2;...
|
| Retrograde endocannabinoid signaling |
1.19 |
8.71e-1 |
118/148 (79.73%) |
GNAI1;NDUFS7;GNB1;...
|
| GnRH signaling pathway |
1.18 |
8.87e-1 |
80/93 (86.02%) |
GNA11;ADCY9;MAPK13;...
|
| Protein export |
1.18 |
8.61e-1 |
17/23 (73.91%) |
SPCS3;HSPA5;SRPRA;...
|
| Dopaminergic synapse |
1.18 |
8.50e-1 |
115/132 (87.12%) |
MAOA;GNAI1;GNB1;...
|
| Glycerophospholipid metabolism |
1.17 |
8.45e-1 |
71/98 (72.45%) |
CDS1;GPD1L;PLPP3;...
|
| Hippo signaling pathway |
1.16 |
8.52e-1 |
120/186 (64.52%) |
BMP2;SMAD1;CCND2;...
|
| Ubiquinone and other terpenoid-quinone biosynthesis |
1.15 |
8.77e-1 |
9/11 (81.82%) |
COQ2;COQ7;HPD;...
|
| Aldosterone synthesis and secretion |
1.15 |
8.77e-1 |
85/98 (86.73%) |
KCNK3;AGT;GNA11;...
|
| Vasopressin-regulated water reabsorption |
1.14 |
8.64e-1 |
40/44 (90.91%) |
ARHGDIB;ADCY9;DYNC1I2;...
|
| Fanconi anemia pathway |
1.14 |
8.48e-1 |
36/54 (66.67%) |
FANCC;PALB2;USP1;...
|
| Biosynthesis of unsaturated fatty acids |
1.14 |
8.36e-1 |
21/27 (77.78%) |
ELOVL5;HACD3;ACOX1;...
|
| Cortisol synthesis and secretion |
1.14 |
8.23e-1 |
58/65 (89.23%) |
KCNK3;AGT;GNA11;...
|
| Morphine addiction |
1.13 |
8.24e-1 |
80/91 (87.91%) |
PDE4B;GNAI1;GNB1;...
|
| DNA replication |
1.13 |
8.09e-1 |
34/36 (94.44%) |
RFC5;POLE3;MCM6;...
|
| Phenylalanine metabolism |
1.13 |
7.89e-1 |
14/17 (82.35%) |
MAOA
|
| Regulation of lipolysis in adipocytes |
1.12 |
8.16e-1 |
52/55 (94.55%) |
NPY;GNAI1;ADCY9;...
|
| Cell adhesion molecules |
1.11 |
8.33e-1 |
118/148 (79.73%) |
ICAM2;ALCAM;CLDN4;...
|
| Platelet activation |
1.10 |
8.68e-1 |
106/124 (85.48%) |
GNAI1;ADCY9;MAPK13;...
|
| Thiamine metabolism |
1.08 |
9.01e-1 |
12/15 (80%) |
AK1;AK2
|
| Mitophagy |
-1.32 |
3.95e-1 |
56/68 (82.35%) |
MFN1;RRAS2;TBK1;...
|
| AMPK signaling pathway |
-1.32 |
4.03e-1 |
106/120 (88.33%) |
PPP2CB;PPP2R1A;PRKAB2;...
|
| Retinol metabolism |
-1.32 |
4.00e-1 |
41/68 (60.29%) |
CYP3A7;CYP3A4;ALDH1A2;...
|
| Hematopoietic cell lineage |
-1.33 |
3.83e-1 |
90/99 (90.91%) |
ITGA1;ITGAM;CD1E;...
|
| Sulfur relay system |
-1.33 |
3.89e-1 |
5/8 (62.5%) |
NFS1;MOCS2
|
| Sulfur metabolism |
-1.34 |
3.85e-1 |
9/10 (90%) |
SQOR;BPNT1;PAPSS2;...
|
| Thyroid hormone signaling pathway |
-1.34 |
3.91e-1 |
112/121 (92.56%) |
NOTCH2;PIK3R2;ATP1B4;...
|
| TNF signaling pathway |
-1.35 |
3.85e-1 |
103/112 (91.96%) |
EDN1;TNFRSF1A;AKT3;...
|
| Porphyrin and chlorophyll metabolism |
-1.36 |
3.83e-1 |
23/43 (53.49%) |
UGT2B4;UGT2B15;HMOX1;...
|
| ECM-receptor interaction |
-1.36 |
3.91e-1 |
80/88 (90.91%) |
TNXB;THBS4;DAG1;...
|
| Salmonella infection |
-1.36 |
4.02e-1 |
198/249 (79.52%) |
RAB5A;TRADD;DYNC2LI1;...
|
| Autophagy |
-1.41 |
3.74e-1 |
113/169 (66.86%) |
PIK3R2;ATG101;INS;...
|
| Complement and coagulation cascades |
-1.42 |
3.64e-1 |
76/85 (89.41%) |
FGA;FGG;F8;...
|
| Antigen processing and presentation |
-1.42 |
3.79e-1 |
60/78 (76.92%) |
RFXAP;NFYC;HLA-DQA1;...
|
| Ferroptosis |
-1.42 |
3.91e-1 |
36/41 (87.8%) |
PCBP1;ATG5;PRNP;...
|
| Prostate cancer |
-1.48 |
2.99e-1 |
93/97 (95.88%) |
CREB3L2;PLAU;HSP90B1;...
|
| Legionellosis |
-1.49 |
2.86e-1 |
51/57 (89.47%) |
TLR5;RAB1A;IL12B;...
|
| Shigellosis |
-1.52 |
2.41e-1 |
180/246 (73.17%) |
BCL10;TBK1;RRAGB;...
|
| IL-17 signaling pathway |
-1.52 |
2.49e-1 |
84/94 (89.36%) |
CXCL6;FADD;IFNG;...
|
| Central carbon metabolism in cancer |
-1.52 |
2.69e-1 |
67/70 (95.71%) |
PFKM;SLC2A1;PIK3CD;...
|
| Leukocyte transendothelial migration |
-1.52 |
2.90e-1 |
90/114 (78.95%) |
MYL12B;ACTN1;EZR;...
|
| Bladder cancer |
-1.55 |
2.67e-1 |
40/41 (97.56%) |
DAPK1;RPS6KA5;MMP9;...
|
| HIF-1 signaling pathway |
-1.55 |
2.82e-1 |
105/109 (96.33%) |
EDN1;LDHB;HIF1A;...
|
| Malaria |
-1.56 |
3.06e-1 |
44/50 (88%) |
SDC2;IL12A;THBS4;...
|
| Inositol phosphate metabolism |
-1.57 |
3.07e-1 |
66/73 (90.41%) |
PI4KB;INPP5F;PIP4K2C;...
|
| Rheumatoid arthritis |
-1.61 |
2.77e-1 |
78/93 (83.87%) |
ITGAL;ATP6V1A;ACP5;...
|
| Protein digestion and absorption |
-1.62 |
3.01e-1 |
78/103 (75.73%) |
ATP1B2;CELA2A;SLC8A1;...
|
| Glycolysis / Gluconeogenesis |
-1.62 |
3.68e-1 |
56/67 (83.58%) |
ADH7;PGK1;ENO3;...
|
| Mineral absorption |
-1.67 |
2.83e-1 |
48/60 (80%) |
ATP1B2;SLC26A6;SLC8A1;...
|
| Viral protein interaction with cytokine and cytokine re... |
-1.70 |
3.11e-1 |
84/100 (84%) |
CCR1;CXCL6;IL2RB;...
|
